Promoter polymorphisms and transcript levels of nicotinic receptor CHRNA5.
- Authors
- Falvella, Felicia S; Galvan, Antonella; Colombo, Francesca; Frullanti, Elisa; Pastorino, Ugo; Dragani, Tommaso A
- Year
- 2010
- Journal
- Journal of the National Cancer Institute
- PMID
- 20733116
- DOI
- 10.1093/jnci/djq264
Chromosomal locus 15q25, implicated in lung cancer risk and nicotine dependence, shows extensive linkage disequilibrium that complicates identification of causal variation. Cholinergic receptor nicotinic alpha5 (CHRNA5) has been identified as a lung cancer risk factor. We identified by sequence analysis three haplotypes (delTTC, insATC, and insTGG) in the 5' promoter region and three at the 3'-untranslated region of CHRNA5. Linkage disequilibrium analysis of the 5' variants showed that the insTGG haplotype is associated with three tightly linked risk alleles (nicotine dependence, lung cancer, and chronic obstructive pulmonary disease). The three CHRNA5 promoter haplotypes were statistically significantly associated with lung CHRNA5 transcript levels, determined by real-time polymerase chain reaction. In nontumor lung parenchyma from 68 patients who underwent lung lobectomy, the delTTC haplotype was associated with the highest CHRNA5 transcript levels (relative quantification units = 1.82), whereas the insTGG haplotype was associated with the lowest (0.88 units, P(diff) < .001, Welch t test; all statistical tests were two-sided). Luciferase reporter assays in human lung cancer cell lines A549, H460, H520, and H596 also showed that the 5' region haplotypes were statistically significantly associated with changes in CHRNA5 promoter activity, whereas the 3'-untranslated region variants were not.
No figures extracted from this document.
No chunks β full text not yet ingested.
No entities extracted from this document yet.
No uploaded files.
No citations found.
In this knowledge base
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| Perspectives on the Ξ±5 nicotinic acetylcholine receptor in lung cancer progression. | Cai J et al. | β | 2025 | β |
| Ion channels in lung cancer: biological and clinical relevance. | Capitani C et al. | β | 2023 | β |
| Alpha5 nicotinic acetylcholine receptor mediated immune escape of lung adenocarcinoma via STAT3/Jab1-PD-L1 signalling. | Zhu P et al. | β | 2022 | β |
| 2018 Langley Award for Basic Research on Nicotine and Tobacco: Bringing Precision Medicine to Smoking Cessation. | Bierut LJ | β | 2020 | β |
| Ξ±5-nAChR contributes to epithelial-mesenchymal transition and metastasis by regulating Jab1/Csn5 signalling in lung cancer. | Chen X et al. | β | 2020 | β |
| Functional Analysis of Promoter Variants in Genes Involved in Sex Steroid Action, DNA Repair and Cell Cycle Control. | Hamdi Y et al. | β | 2019 | β |
| Genetic susceptibility variants for lung cancer: replication study and assessment as expression quantitative trait loci. | Pintarelli G et al. | β | 2017 | β |
| Pharmacogenetic study of seven polymorphisms in three nicotinic acetylcholine receptor subunits in smoking-cessation therapies. | Pintarelli G et al. | β | 2017 | β |
| Promoter IV-BDNF deficiency disturbs cholinergic gene expression of CHRNA5, CHRM2, and CHRM5: effects of drug and environmental treatments. | Sakata K et al. | β | 2017 | β |
| The Oncogenic Functions of Nicotinic Acetylcholine Receptors. | Zhao Y | β | 2016 | β |
| A multiancestry study identifies novel genetic associations with CHRNA5 methylation in human brain and risk of nicotine dependence. | Hancock DB et al. | β | 2015 | β |
| Ion channel expression as promising cancer biomarker. | Lastraioli E et al. | β | 2015 | β |
| Response to Transdermal Selegiline Smoking Cessation Therapy and Markers in the 15q24 Chromosomal Region. | Sarginson JE et al. | β | 2015 | β |
| The role of haplotype in 15q25.1 locus in lung cancer risk: results of scanning chromosome 15. | Ji X et al. | β | 2015 | β |
| A signal peptide missense mutation associated with nicotine dependence alters Ξ±2*-nicotinic acetylcholine receptor function. | Dash B et al. | β | 2014 | β |
| Ξ±5 Nicotinic acetylcholine receptor mediates nicotine-induced HIF-1Ξ± and VEGF expression in non-small cell lung cancer. | Ma X et al. | β | 2014 | β |
| Cis-regulatory variants affect CHRNA5 mRNA expression in populations of African and European ancestry. | Wang JC et al. | β | 2013 | β |
| Functional characterization of SNPs in CHRNA3/B4 intergenic region associated with drug behaviors. | Flora AV et al. | β | 2013 | β |
| Functional effect of polymorphisms in 15q25 locus on CHRNA5 mRNA, bulky DNA adducts and TP53 mutations. | Tekpli X et al. | β | 2013 | β |
| Multiple isoforms and differential allelic expression of CHRNA5 in lung tissue and lung adenocarcinoma. | Falvella FS et al. | β | 2013 | β |
| Smoking and genetic risk variation across populations of European, Asian, and African American ancestry--a meta-analysis of chromosome 15q25. | Chen LS et al. | β | 2012 | β |
| The CHRNA5-A3-B4 gene cluster in nicotine addiction. | Berrettini WH et al. | β | 2012 | β |
| The genetics of substance dependence. | Wang JC et al. | β | 2012 | β |
| Transgenic over expression of nicotinic receptor alpha 5, alpha 3, and beta 4 subunit genes reduces ethanol intake in mice. | Gallego X et al. | β | 2012 | β |
| A case-control study of a sex-specific association between a 15q25 variant and lung cancer risk. | Wei C et al. | β | 2011 | β |
| CHRNA5 as negative regulator of nicotine signaling in normal and cancer bronchial cells: effects on motility, migration and p63 expression. | Krais AM et al. | β | 2011 | β |
| Chromosome 15q24-25.1 variants, diet, and lung cancer susceptibility in cigarette smokers. | Sakoda LC et al. | β | 2011 | β |
| Chromosome 15q25 (CHRNA3-CHRNA5) variation impacts indirectly on lung cancer risk. | Wang Y et al. | β | 2011 | β |
| Chronic obstructive pulmonary disease and lung cancer: new molecular insights. | Adcock IM et al. | β | 2011 | β |
| Genetic vulnerability and susceptibility to substance dependence. | Bierut LJ | β | 2011 | β |
| In vitro and ex vivo analysis of CHRNA3 and CHRNA5 haplotype expression. | Doyle GA et al. | β | 2011 | β |
| Nicotinic acetylcholine receptor variants associated with susceptibility to chronic obstructive pulmonary disease: a meta-analysis. | Zhang J et al. | β | 2011 | β |